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Reproductive toxicity testing is one of 
the most complex, expensive and labor in-
tensive fields of toxicology (Leist et al., 
2013; Wobus and Löser, 2011; Hengstler, 
2011; Krause et al., 2013). The catastrophic 
consequences of thalidomide-induced tera-
togenesis (Schmahl et al., 1996; Sterz et al., 
1987) drastically demonstrate the funda-
mental importance of reliable developmen-
tal toxicity tests for human safety (van 
Thriel and Stewart, 2012a, b; van Thriel et 
al., 2012; Frimat et al., 2010; Kadereit et 
al., 2012; Marques et al., 2012; Duydu et 
al., 2011). Currently, large efforts are un-
dertaken to establish in vitro test systems of 
developmental toxicity (Krug et al., 2013; 
Strikwold et al., 2013; Seiler et al., 2011; 
Bolt, 2013). Recently, human embryonic 
stem cell based in vitro test systems have 
been established that recapitulate critical 
periods of human early development (Krug 
et al., 2013; Zimmer et al., 2011;2012). 
During this differentiation period the differ-
entiating stem cells are exposed to test 
compounds to study their influence on ge-
nome-wide expression patterns. Evaluation 
of the deregulated genes is usually based on 
methods of pattern analysis and identifica-
tion of overrepresented motifs which initial-
ly has been introduced for characterization 
of tumor tissue (Kammers et al., 2011; Lohr 
et al., 2012; Botling et al., 2013; Schmidt et 
al., 2008, 2012; Cadenas et al., 2010). 
These studies have clearly shown that com-
pounds known to induce developmental 
toxicity cause different alterations in gene 
expression than negative control com-
pounds (Krug et al., 2013; Krause et al., 
2013). Despite of this success stem cell 
based in vitro studies are still not broadly 
applied in routine toxicity testing. The ma-
jority of currently published studies are still 
performed in vivo (e.g. Gao et al., 2012; 
Saegusa et al., 2012; Ogawa et al., 2012; 
Romano et al., 2012; Lim et al. 2007; Burns 
and Korack, 2012; Shiraki et al., 2012; Bal-
ansky et al., 2012). Of course in vitro sys-
tems still have the limitation that it is diffi-
cult to derive NOAELS (Godoy et al., 
2013). Although currently large efforts are 
undertaken to define in vivo relevant con-
centrations for in vitro testing (Mielke et 
al., 2011) and to correlate in vitro and in 
vivo data (Heise et al., 2012; Schug et al., 
2013) the use of in vitro systems in the risk 
evaluation process is still controversial. 
Their application for harzard identification 
and to filter problematic compounds is 
more generally accepted. Although the re-
cently published transcriptomic studies in 
developing stem cells represent a critical 
progress they still leave some important 
questions open: 
 How are the compound induced gene 
expression alterations linked to adverse 
effects? Which expression responses 
represent reversible ‘harmless’ efforts 
of the cells to reestablish their equilib-
rium? Which genes, in contrast, indi-
cate mechanisms leading to reversible 
consequences?  
 What is the optimal concentration 
range for transcriptomics studies? Is it 
acceptable to use the EC10 as practiced 
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in most studies? Or do already slightly 
cytotoxic concentrations induce cell 
death associated expression signatures 
which dilute the specific sigals?  
 Do differentiating embryonic stem 
cells in vitro show waves of develop-
ment with susceptible periods similar 
to the in vivo situation?  
Answers to these critical questions 
would certainly improve the general ac-
ceptance of the recently established FP7 
ESNATS in vitro test systems (Bolt, 2013; 
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